• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名多发性骨髓瘤患者发生慢性淋巴细胞白血病:克隆性不同的第二种恶性肿瘤的免疫学证明。

Chronic lymphatic leukemia developing in a patient with multiple myeloma: immunologic demonstration of a clonally distinct second malignancy.

作者信息

Zalcberg J R, Cornell F N, Ireton H J, McGrath K M, McLachlan R, Woodruff R K, Wiley J S

出版信息

Cancer. 1982 Aug 1;50(3):594-7. doi: 10.1002/1097-0142(19820801)50:3<594::aid-cncr2820500335>3.0.co;2-e.

DOI:10.1002/1097-0142(19820801)50:3<594::aid-cncr2820500335>3.0.co;2-e
PMID:7093901
Abstract

A patient with multiple myeloma who subsequently developed chronic lymphocytic leukemia is reported. Initial studies demonstrated clinical and hematological features of multiple myeloma with an IgM lambda paraprotein. Skeletal disease was a significant presenting feature, although relapse occurred in extraosseous sites, particularly the pleura. He developed chronic lymphatic leukemia 31 months later and immunological studies showed the malignant lymphocytes to have kappa (Kappa) light chain surface immunoglobulin, demonstrating separate clonal origin of this patient's two B-cell malignancies.

摘要

报告了一例多发性骨髓瘤患者,该患者随后发展为慢性淋巴细胞白血病。初始研究显示多发性骨髓瘤的临床和血液学特征,伴有IgM λ副蛋白。骨骼疾病是一个显著的表现特征,尽管复发发生在骨外部位,尤其是胸膜。31个月后他发展为慢性淋巴细胞白血病,免疫学研究显示恶性淋巴细胞具有κ(kappa)轻链表面免疫球蛋白,表明该患者的两种B细胞恶性肿瘤起源不同。

相似文献

1
Chronic lymphatic leukemia developing in a patient with multiple myeloma: immunologic demonstration of a clonally distinct second malignancy.一名多发性骨髓瘤患者发生慢性淋巴细胞白血病:克隆性不同的第二种恶性肿瘤的免疫学证明。
Cancer. 1982 Aug 1;50(3):594-7. doi: 10.1002/1097-0142(19820801)50:3<594::aid-cncr2820500335>3.0.co;2-e.
2
[Chronic lymphoid leukemia and multiple myeloma].[慢性淋巴细胞白血病和多发性骨髓瘤]
Rev Rhum Mal Osteoartic. 1976 Jan;43(1):1-9.
3
Immunoglobulin receptors on human leukocytes. IV. Differences between bone marrow and blood cells in multiple myeloma and chronic lymphocytic leukemia: effects of therapy.
J Lab Clin Med. 1973 Oct;82(4):611-8.
4
Chronic lymphocytic leukaemia with subsequent development of multiple myeloma. Evidence of two B-lymphocyte clones and of myeloma-induced suppression of secretion of an M-component and of normal immunoglobulins.慢性淋巴细胞白血病继发多发性骨髓瘤。存在两个B淋巴细胞克隆的证据,以及骨髓瘤诱导的M成分和正常免疫球蛋白分泌受抑制的证据。
Scand J Haematol. 1978 Sep;21(3):256-64.
5
Absence of lymphocyte immunoglobulin production in chronic lymphocytic leukemia and multiple myeloma.慢性淋巴细胞白血病和多发性骨髓瘤中淋巴细胞免疫球蛋白产生的缺失。
Ann Intern Med. 1977 Jun;86(6):750-2. doi: 10.7326/0003-4819-86-6-750.
6
Coincident chronic lymphocytic leukemia and osteosclerotic multiple myeloma.同时存在的慢性淋巴细胞白血病和骨硬化性多发性骨髓瘤。
Blood. 1981 Mar;57(3):617-9.
7
Idiotypic immunoglobulin structures on blood lymphocytes in human plasma cell myeloma.
Immunol Rev. 1977;34:139-64. doi: 10.1111/j.1600-065x.1977.tb00371.x.
8
Multiple myeloma and chronic lymphocytic leukemia in a single individual.同一患者同时患有多发性骨髓瘤和慢性淋巴细胞白血病。
Arch Intern Med. 1977 Feb;137(2):232-5. doi: 10.1001/archinte.137.2.232.
9
Multiple myeloma terminating in lymphocytic leukemia with B-lymphocyte membrane markers.多发性骨髓瘤最终发展为具有B淋巴细胞膜标志物的淋巴细胞白血病。
Am J Hematol. 1977;3:153-63. doi: 10.1002/ajh.2830030206.
10
B-cell malignancy and monoclonal gammopathy, and idiotype of cell surface and serum immunoglobulin.B细胞恶性肿瘤和单克隆丙种球蛋白病,以及细胞表面和血清免疫球蛋白的独特型。
Jpn J Clin Oncol. 1983 Sep;13(3):533-42.

引用本文的文献

1
Emergence of overt myeloma in a patient with chronic lymphocytic leukemia on ibrutinib therapy.一名接受伊布替尼治疗的慢性淋巴细胞白血病患者出现明显的骨髓瘤。
Clin Case Rep. 2020 Jul 15;8(9):1797-1801. doi: 10.1002/ccr3.3019. eCollection 2020 Sep.
2
Lymphoproliferations in the bone marrow: identification and evolution, classification and staging.骨髓中的淋巴细胞增殖:识别与演变、分类与分期
J Clin Pathol. 1984 Mar;37(3):233-54. doi: 10.1136/jcp.37.3.233.